Advertisement

Metabolic Brain Disease

, Volume 29, Issue 2, pp 409–419 | Cite as

The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors

  • Wiliam DavisEmail author
  • Susan J. van Rensburg
  • Frans J. Cronje
  • Lindiwe Whati
  • Leslie R. Fisher
  • Lize van der Merwe
  • Dieter Geiger
  • M. Shafick Hassan
  • Tandi Matsha
  • Rajiv T. Erasmus
  • Maritha J. Kotze
Original Paper

Abstract

The previously reported link between homocysteine and obesity, both identified as established risk factors for multiple sclerosis (MS), has not previously been studied in relation to the fat mass and obesity-associated (FTO) gene. Aim: To investigate the mechanism underlying homocysteine accumulation in MS patients. A total of 114 patients and 195 population-matched controls were analysed for the FTO rs9939609 polymorphism. Homocysteine levels were measured in a subgroup of 60 patients and 87 controls screened for multiple vascular risk factors. After adjustment for potential confounders, the risk-associated FTO rs9939609 A-allele was associated with raised homocysteine levels (p = 0.003) in patients diagnosed with MS, but not in controls. Homocysteine levels correlated positively with body mass index (BMI) (p = 0.045) and total cholesterol levels (p = 0.048). Both homocysteine (p = 0.011) and BMI (p = 0.017) were significantly reduced with higher intake of folate in the diet. Higher BMI also correlated with increased intake of saturated/trans fat (p < 0.01) and low physical activity (p < 0.006). Daily intake of at least five fruits and vegetables had a favourable lowering effect on the Expanded Disability Status Scale (EDSS) (p = 0.035), while smoking increased MS disability (p < 0.001). This study has shown for the first time that having a diagnosis of MS moderates the effect of the FTO rs9939609 polymorphism on homocysteine levels. This is consistent with the role of FTO in demethylation and epigenetic changes. Identification of FTO rs9939609 reinforces the importance of adequate fruit, vegetable and folate and restriction of saturated/trans fat intake in the diet.

Keywords

Multiple sclerosis (MS) Homocysteine FTO Obesity Body mass index (BMI) 

Notes

Acknowledgments

We gratefully acknowledge the financial support given by the National Health Laboratory Service, the Medical Research Council (MRC) of South Africa and the University of Stellenbosch. The MRC Biostatistics Unit is acknowledged for statistics support. Study participants are acknowledged for their willingness and cooperation to participate in this study.

Disclosure of Potential Conflict of Interest

Professors SJ van Rensburg and MJ Kotze are listed as inventors on patent number 2010/00058. Prof Kotze is also a director and shareholder of Gknowmix (Pty) Ltd. that has developed a database tool for research translation under the auspices of the Innovation Centre of the South African Medical Research Council. Prof SJ van Rensburg applied the Gknowmix database tool and open innovation genetic testing service delivery model for development of the Demyelinating Diseases GeneScreen™. Together with Dr Frans Cronje, a treatment regimen was developed for application with this genomic solution (patent pending). Registered dietician Mrs Lindiwe Whati developed the nutrition questionnaire used in this study. The remaining authors declared no conflict of interest. No writing assistance was utilised in the preparation of this manuscript.

References

  1. Adeyemo A, Chen G, Zhou J, Shriner D, Doumatey A, Huang H, Rotimi C (2010) FTO genetic variation and association with obesity in West Africans and African Americans. Diabetes 59:1549–54PubMedCentralPubMedCrossRefGoogle Scholar
  2. Alatab S, Hossein-nezhad A, Mirzaei K, Mokhtari F, Shariati G, Najmafshar A (2011) Inflammatory profile, age of onset, and the MTHFR polymorphism in patients with multiple sclerosis. J Mol Neurosci 44:6–11PubMedCrossRefGoogle Scholar
  3. Almen MS, Jacobsson JA, Moschonis G, Benedict C, Chrousos GP, Fredriksson R, Schiöth HB (2012) Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics 99:132–7PubMedCrossRefGoogle Scholar
  4. da Silva CF, Zandoná MR, Vitolo MR, Campagnolo PD, Rotta LN, Almeida S, Mattevi VS (2013) Association between a frequent variant of the FTO gene and anthropometric phenotypes in Brazilian children. BMC Med Gen 14(1):34CrossRefGoogle Scholar
  5. Das M, Ghose M, Borah NC, Choudhury N (2010) A community based study of the relationship between homocysteine and some of the life style factors. IJCB 25(3):295–301. doi: 10.1007/s12291-010-0044-8 PubMedCentralPubMedGoogle Scholar
  6. Fekih Mrissa N, Mrad M, Klai S, Zaouali J, Sayeh A, Mazigh C, Nsiri B, Machgoul S, Gritili N, Mrissa R (2013) Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients. Clin Neurol Neurosurg 115(9):1657–1660. doi: 10.1016/j.clineuro.2013.02.025 PubMedCrossRefGoogle Scholar
  7. Fokkema MR, Gilissen MF, Van Doormaal JJ, Volmer M, Kema IP, Muskiet FAJ (2003) Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. Clin Chem 49:818–21PubMedCrossRefGoogle Scholar
  8. Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–94PubMedCentralPubMedCrossRefGoogle Scholar
  9. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM, Levine AS, Lindblom J, Schiöth HB (2008) The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149:2062–71PubMedCrossRefGoogle Scholar
  10. Gerken T, Girard CA, Tung YC et al (2007) The obesity associated FTO gene encodes a 2-oxyglutarate-dependent nucleic acid demethylase. Science 18(8):1469–1472CrossRefGoogle Scholar
  11. Gonzalez-Gross M, Benser J, Breidenassel C et al (2012) Gender and age influence blood folate, vitamin B12, vitamin B6, and homocysteine levels in European adolescents: the Helena Study. Nutr Res 32:817–26PubMedCrossRefGoogle Scholar
  12. He l, Zeng H, Li F et al (2010) Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab 299(6):E1061–E1065. doi: 10.1152/ajpendo.00367.2010 PubMedCrossRefGoogle Scholar
  13. Hedström AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 18:1334–6PubMedCrossRefGoogle Scholar
  14. Jahromi SR, Toghae M, Jahromi MJR, Aloosh M (2012) Dietary pattern and risk of multiple sclerosis. Iran J Neurol 11(2):47–53PubMedCentralPubMedGoogle Scholar
  15. Jia G, Fu Y, Zhao X et al (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7:885–7PubMedCentralPubMedCrossRefGoogle Scholar
  16. Kant AK (2000) Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 72:929–36PubMedGoogle Scholar
  17. Karra E, O’Daly OG, Choudhury AI et al (2013) A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest 123:3539–51PubMedCentralPubMedCrossRefGoogle Scholar
  18. Kim S, Lim IK, Park GH, Paik WK (1997) Biological methylation of myelin basic protein: enzymology and biological significance. Int J Biochem Cell Biol 29:743–51PubMedCrossRefGoogle Scholar
  19. Klotz L, Farkas M, Bain N et al (2010) The variant methylenetetrahydrofolate reductase c.1298A > C (p.E429A) is associated with multiple sclerosis in a German case-control study. Neurosci Lett 468:183–5PubMedCrossRefGoogle Scholar
  20. Koga T, Claycombe K, Meydani M (2002) Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161:365–374PubMedCrossRefGoogle Scholar
  21. Kotze MJ, de Villiers JNP, Rooney RN, Grobbelaar JJ, Mansvelt EPG, Bouwens CSH, Carr J, Stander I, du Plessis L (2001) Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells Mol Dis 27:44–53PubMedCrossRefGoogle Scholar
  22. Koz ST, Etem EO, Baydas G, Yuce H, Ozercan HI, Kuloğlu T, Koz S, Etem A, Demir N (2012) Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res 1484:29–38PubMedCrossRefGoogle Scholar
  23. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRefGoogle Scholar
  24. Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 80:548–52PubMedCentralPubMedCrossRefGoogle Scholar
  25. Leiherer A, Mündlein A, Drexel H (2013) Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul Pharmacol 58(1–2):3–20PubMedCrossRefGoogle Scholar
  26. Liu Y, Liu Z, Song Y et al (2010) Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity 18:1619–24PubMedCrossRefGoogle Scholar
  27. Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS (2013) Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 136:2298–304PubMedCentralPubMedCrossRefGoogle Scholar
  28. Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2010) Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 74:1041–7PubMedCentralPubMedCrossRefGoogle Scholar
  29. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146PubMedCrossRefGoogle Scholar
  30. Meng S, Ciment S, Jan M, Tran T, Pham H, Cueto R, Yang XF, Wang H (2013) Homocysteine induces inflammatory transcriptional signaling in monocytes. Front Biosci 18:685–95CrossRefGoogle Scholar
  31. Modi G, Mochan A, du Toit M, Stander I (2008) Multiple sclerosis in South Africa. S Afr Med J 98:391–3PubMedGoogle Scholar
  32. Morra VB, Coppola G, Orefice G, De Michele G, Vacca G, Filla A, Bonavita V (2004) Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. Neurology 62:829–30PubMedCrossRefGoogle Scholar
  33. Niu Y, Zhao X, Wu YS, Li MM, Wang XJ, Yang YG (2013) N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics 11:8–17PubMedCrossRefGoogle Scholar
  34. Nygård O, Vollset SE, Refsum H (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274(19):1526–1533PubMedCrossRefGoogle Scholar
  35. O K Lynn EG, Chung YH, Siow YL, Man RY, Choy PC (1998) Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta 1393:317–24CrossRefGoogle Scholar
  36. Obeid R, Hermann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994–3005PubMedCrossRefGoogle Scholar
  37. Ortega-Azorin C, Sorli JV, Asensio EM et al (2012) Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol 11:137PubMedCentralPubMedCrossRefGoogle Scholar
  38. Russo C, Morabito F, Luise F et al (2008) Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 255:64–9PubMedCrossRefGoogle Scholar
  39. Rodriquez M (2009) Have we finally identified an autoimmune demyelinating disease? Ann Neurol 66:572–573CrossRefGoogle Scholar
  40. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217–46PubMedCrossRefGoogle Scholar
  41. Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Tremlett H (2012) Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA 308(3):247–256PubMedCrossRefGoogle Scholar
  42. Sibbritt T, Patel HR, Preiss T (2013) Mapping and significance of the mRNA methylome. Wiley Interdiscip Rev RNA 4(4):397–422PubMedCrossRefGoogle Scholar
  43. Sidhu D, Naugler C (2012) Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med 172:1707–10PubMedCrossRefGoogle Scholar
  44. Szvetko AL, Fowdar J, Nelson J et al (2007) No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort. J Neurol Sci 252:49–52PubMedCrossRefGoogle Scholar
  45. van Rensburg SJ, Kotze MJ, Hon D et al (2006) Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis. Metab Brain Dis 21:121–37PubMedCrossRefGoogle Scholar
  46. van Rensburg SJ, van Toorn R (2010) The controversy of CCSVI and iron in multiple sclerosis Is ferritin the key? Neurology 75(18):1581–1582PubMedCrossRefGoogle Scholar
  47. Vaya A, Rivera L, Hernandez-Mijares A, de la Fuente M, Solá E, Romagnoli M, Alis R, Laiz B (2012) Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance. Clin Hemorheol Microcirc 52:49–56PubMedGoogle Scholar
  48. Voet D, Voet JG (2004) Biochemistry, 3rd edn. Hoboken, Wiley & Sons, New York, p 974Google Scholar
  49. Zappacosta B, Mastroiacovo P, Persichilli S et al (2013) Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. Nutrients 5:1531–43PubMedCentralPubMedCrossRefGoogle Scholar
  50. Zheng G, Dahl JA, Niu Y, Fu Y, Klungland A, Yang YG, He C (2013) Sprouts of RNA epigenetics: The discovery of mammalian RNA demethylases. RNA Biol 10(6):915–8PubMedCrossRefGoogle Scholar
  51. Zhu Y, He ZY, Liu HN (2011) Meta-analysis of the relationship between homocysteine, vitamin B(1)(2), folate, and multiple sclerosis. J Clin Neurosci 18:933–8PubMedCrossRefGoogle Scholar
  52. Zoccolella S, Tortorella C, Iaffaldano P, Direnzo V, D’Onghia M, Paolicelli D, Livrea P, Trojano M (2012) Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender. J Neurol 259:2105–10PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Wiliam Davis
    • 1
    Email author
  • Susan J. van Rensburg
    • 1
  • Frans J. Cronje
    • 2
  • Lindiwe Whati
    • 3
  • Leslie R. Fisher
    • 4
  • Lize van der Merwe
    • 5
    • 6
  • Dieter Geiger
    • 4
  • M. Shafick Hassan
    • 7
  • Tandi Matsha
    • 7
  • Rajiv T. Erasmus
    • 1
  • Maritha J. Kotze
    • 3
    • 4
  1. 1.Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service (NHLS) and Faculty of Medicine and Health SciencesStellenbosch UniversityCape TownSouth Africa
  2. 2.Interdisciplinary Health Sciences, Faculty of Medicine and Health SciencesStellenbosch UniversityCape TownSouth Africa
  3. 3.Genetic Care CenterTygerberg Academic HospitalCape TownSouth Africa
  4. 4.Division of Anatomical Pathology, Department of Pathology, Faculty of Medicine and Health SciencesStellenbosch UniversityCape TownSouth Africa
  5. 5.Department of Molecular Biology and Human Genetics, Faculty of Medicine and Health SciencesStellenbosch UniversityCape TownSouth Africa
  6. 6.Department of StatisticsUniversity of the Western CapeCape TownSouth Africa
  7. 7.Faculty of Health and Wellness ScienceCape Peninsula University of TechnologyCape TownSouth Africa

Personalised recommendations